Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00386971 · ClinicalTrials.gov registry record · NA
Effects of L-Carnitine on Postprandial Clearance of Triglyceride-rich Lipoproteins in HIV Patients on HAART
A NA study, sponsored by University of California, Davis.
- Completed
- Registry status
- NA
- Development phase
- 13
- Enrollment target
NCT00386971 is a NA study that has completed, run by University of California, Davis. The registered enrollment target is 13 participants.
The verdict
NCT00386971, a NA study, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
Study Summary
Included in this study will be patients with HIV and being treated with highly active antiretroviral medications (HAART) including protease inhibitors (PI) or non-nucleoside reverse transcriptase inhibitors (NNRTI). Protease inhibitors and non-nucleoside reverse transcriptase inhibitors are very common medications in HIV treatment and are usually given with other medications as part of a standard treatment for HIV (HAART). We hope to learn more about how the levels of cholesterol-and triglyceride-carrying particles (lipoproteins) are affected by a nutritional supplement, L-Carnitine, in HIV-positive patients treated with antiretroviral medications.
Interventions
- OTHER placebo
- DIETARY_SUPPLEMENT L-carnitine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2006-10 |
| Est. Completion | 2009-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00386971
The ClinicalTrials.gov registry entry for NCT00386971 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT00386971 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00386971 about?
NCT00386971 is a clinical study titled "Effects of L-Carnitine on Postprandial Clearance of Triglyceride-rich Lipoproteins in HIV Patients on HAART". Included in this study will be patients with HIV and being treated with highly active antiretroviral medications (HAART) including protease inhibitors (PI) or non-nucleoside reverse transcriptase inhibitors (NNRTI). Protease inhibitors and non-nucleoside reverse transcriptase inhibitors are very com...
What is the current status of trial NCT00386971?
This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2006-10. Estimated completion is 2009-12.
What interventions are being tested in trial NCT00386971?
The interventions under investigation include: placebo (OTHER), L-carnitine (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00386971?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.